EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Utility and Acceptability of Perskindol Spray and Gel as a Topical Treatment for Musculoskeletal Pain

Puchong Padungsutt, Warat Tassanawipas, Agripino Beng Javier, Paul Nierva

International Journal of Patient-Centered Healthcare · 2019

DOI: 10.4018/ijpch.2019010103 ↗
AbstractBibliografische Angaben

Abstract

Perskindol (study treatment) is a topical pain treatment in gel or spray form which contains menthol and herbal components. These two open-label, prospective, nonrandomized monadic studies in the Philippines and Thailand investigated the utility and acceptability of the study treatment for musculoskeletal pain. Adults with musculoskeletal pain were advised to use the study gel or spray as needed for up to 7 days. Their usage, perceptions, and response to treatment were assessed by patient diary and structured questionnaire. At study end, patients from both studies generally rated the study treatment higher in terms of ease of use, onset, and duration of pain relief, low potential for skin irritation and overall rating compared with their previous treatment. Differentiation analysis showed that the study treatment addressed patient preferences perceived as important, which were rapid relief of pain and ease of use. These findings suggest that the study spray and gel are useful and acceptable topical treatments for musculoskeletal pain and may be considered in self-directed pain management.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →